Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects

NACompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Dry Eye
Interventions
DRUG

Propylene Glycol, 0.6% eye drops

Commercially available eye drops used during Treatment Phase

DRUG

Preservative-free 0.9% Saline solution

Commercially available solution used as Run-in (1 drop in each eye 4 times a day for 15 days) and during Treatment Phase

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01967147 - Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects | Biotech Hunter | Biotech Hunter